Asian longhorned tick threatens U.S. livestock and health
See the interactive map from the USDA here
The tick poses a risk to people, pets, and livestock. It's especially harmful to livestock and has been known to break out into an infestation on one animal, leading to great stress and reducing growth and production. A severe infestation on one animal can even cause the animal to die from blood loss. Yikes!
Aside from its infestation capabilities, the tick also carries disease. Livestock, in particular, is at risk of catching bovine theileriosis from a longhorned tick. Bovine theileriosis is a blood-borne parasite that, when left untreated, can cause an animal to die.
Outside of the US, the tick has been linked to carrying human diseases such as Japanese Spotted Fever. However, the longhorned ticks found in the US have not been found to transmit human pathogens such as Lyme disease. That's good news for now! It's been found in a lab that this tick species could become a carrier for Rocky Mountain Spotted Fever
This species of tick is unique in that the females can reproduce without a male. This is why they are efficient at spreading once introduced into a new geographic region. The tick was first identified in the US in 2017 and has since spread to 21 eastern states.
The species was first found in Missouri in 2021. It's been identified in both the St. Louis and Kansas City metro areas, and traces of the tick have been found in Greene County. A live specimen, however, hasn't been confirmed yet in Springfield. The tick has also been identified in Benton, Washington, Boone, Searcy, and Independence counties in Northern Arkansas.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
8 hours ago
- Business Wire
Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last patient, last visit in its ongoing Phase 2 clinical trial (NCT05561751) evaluating the safety and efficacy of GPC-100 (burixafor) in combination with propranolol and G-CSF in multiple myeloma patients undergoing autologous stem cell transplant (ASCT). Topline results from the study are expected in the fourth quarter of 2025. The randomized, open-label, multicenter study is designed to assess whether GPC-100, a small molecule CXCR4 antagonist, can improve CD34+ hematopoietic stem cell mobilization from the bone marrow into the peripheral blood, where they can be collected via leukapheresis for use in ASCT. In data presented at ASH 2024, GPC-100 appears to be well differentiated in terms of the speed with which it mobilizes stem cells compared to currently approved stem cell mobilization treatments. Dr. Muthalagu Ramanathan, Director of the Myeloma Program and Medical Co-Director of the Blood and Marrow Transplant and CAR-T Program at U Mass Memorial Health noted that 'traditionally, patients undergoing mobilization are required to come, as an outpatient, the night before their procedure to receive the mobilization injection — a process that adds logistical challenges. The study drug GPC100 needed to be administered just 45 minutes before stem cell collection and resulted in a successful mobilization, significantly improving the patient experience. This is a true blessing for our frail myeloma patients.' In addition to multiple myeloma and a planned Phase 1 study in acute myeloid leukemia (AML) patients, the company is also in discussions for potential collaborations that would utilize GPC-100's rapid and safe mobilization of stem cells in cell and gene therapy settings. About GPC-100 GPC-100 (burixafor) is a highly selective small molecule antagonist of CXCR4, a chemokine receptor that plays a central role in retaining hematopoietic stem cells in the bone marrow niche. By blocking CXCR4, GPC-100 may enhance the mobilization of these cells into the peripheral blood for collection and use in autologous stem cell transplant (ASCT) procedures. Originally developed by GPCR Therapeutics, Inc., GPC-100 became part of Exicure's pipeline following the company's acquisition in January 2025. In addition to multiple myeloma, GPC-100 is also being considered in acute myeloid leukemia (AML) and other diseases where improved stem cell mobilization could help enable more efficient and effective treatment approaches, such as sickle cell disease, rare diseases requiring autologous transplant, and cell and gene therapy settings. About Exicure Exicure, Inc. (Nasdaq: XCUR) is a clinical-stage biotechnology company developing therapies to address key challenges in hematologic diseases. The company's lead program, GPC-100, is being evaluated for its ability to improve stem cell mobilization in multiple myeloma, sickle cell disease, and in support of cell and gene therapy. It is also being studied as a potential chemosensitizing agent in acute myeloid leukemia (AML). For more information, visit
Los Angeles Times
8 hours ago
- Los Angeles Times
‘Relentlessly debilitating,' the chronic symptoms of Lyme disease
Grammy award-winning pop star Justin Timberlake, 44, recently took to Instagram to share his diagnosis of Lyme disease, a bacterial infection that he said was, 'relentlessly debilitating, both mentally and physically.' His statement comes on the heels of criticism from fans who felt he was under-performing during his recent world tour. 'When I first got the diagnosis I was shocked for sure,' the post stated. 'But, at least I could understand why I would be onstage and in a massive amount of nerve pain or, just feeling crazy fatigue or sickness.' Lyme disease is an infectious disease caused by borrelia burgdorferi, a bacterial species that can spread to people and animals from the bite of a deer tick — also called a black-legged tick — carrying the bacteria, according to the Mayo Clinic. Experts say ticks that carry the bacteria live throughout most of the United States, although the incidence of Lyme disease is far less prevalent in California than it is in the American Northeast, Midwest and mid-Atlantic states. (The disease is named after the town of Lyme, Connecticut, where an outbreak was first identified in the 1970s.) In California, western black-legged ticks are carriers of Lyme disease and are commonly found in northern coastal counties and in the foothills of the Sierra Nevada mountains, according to the California Department of Public Health. Between 2013 and 2019, there were 904 new cases of Lyme disease in the state. During that time period, the average rates of Lyme disease were highest in Santa Cruz (4 cases per 100,000 people), Humboldt (about 3 cases per 100,000 people) and Sonoma Counties (about 2 cases per 100,000 people). Lyme disease often goes undiagnosed 'due to the breadth and migratory nature of its symptoms—ranging from headaches and fatigue to joint pain, body aches, balance issues, memory loss, myocarditis, anxiety, insomnia, and depression,' the Bay Area Lyme Foundation, a nonprofit that studies the disease, stated in a post on X. Most people completely recover from the disease when treated with a two- to four-week course of antibiotics. Others have prolonged symptoms of fatigue, body, aches or difficulty thinking, according to the U.S. Centers for Disease Control and Prevention. When a bacteria-infected tick bites a person, or animal, the bacteria is released from the mouth of the tick and into the bloodstream, where it can then spread throughout the body, according to Bay Area Lyme Foundation. If a tick becomes attached to your skin, the CDC recommends you remove it as soon as possible. Consult your health care provider if you show any symptoms of the disease. Your body's reaction to the infection varies from person to person and symptoms show up in stages. Some people with Lyme disease don't have symptoms in the early stages of the infection, according to the Mayo Clinic. Common symptoms of Lyme disease are fever, rash, facial paralysis, an irregular heartbeat, and arthritis. These symptoms can happen in stages. During the first stage, which occurs 3 to 30 days after a tick bite, a person can develop a circular rash around the site of the bite. The rash can become clear in the center, and resemble a target or bull's-eye. During this first stage, infected people can experience a fever, headache, extreme tiredness, joint stiffness, muscle aches and pains or swollen lymph nodes. In the second stage, which occurs three to 10 weeks after a bite, symptoms can escalate. They include: Symptoms in the third stage of the disease, which begins two to 12 months after a tick bite, include arthritis in large joints, particularly the knees. Pain, swelling or stiffness may last for a long time or can come and go. People with prolonged symptoms of Lyme disease, called Post-Treatment Lyme Disease Syndrome, usually get better over time without additional antibiotics, but it can take many months to feel completely well, according to the CDC. The cause of pro-longed symptoms is currently unknown. Ticks are commonly found in outdoor areas with grass, shrubs, rocks, logs and fallen leaves. You don't have to avoid these areas, but should instead wear protective clothing to prevent a tick from latching onto your skin. Before you go on your outdoor activity, plan to wear long-sleeve shirts and pants. With your protective clothes on, apply insect repellent to garments and exposed skin, according to the state public health department. During your hike, check yourself and any pets for ticks that might be crawling on you. If you do see a tick, remove it right away. When you return home from your excursion, inspect your clothes, body and scalp for any ticks. Toss the tick-free clothes in the laundry and take a shower. If you found a tick on your clothes put clothing items in a hot dryer for 10 minutes, that will kill the insect. The California Department of Public Health recommends you continue to check your body for any sign of ticks for three days after being outside in areas where ticks reside.
Hamilton Spectator
9 hours ago
- Hamilton Spectator
Justin Timberlake reveals ‘relentlessly debilitating' Lyme disease symptoms — Do you live in Ontario's high risk areas?
Justin Timberlake has Lyme disease. The famous pop star confirmed his battle with 'relentlessly debilitating' Lyme disease symptoms in an Instagram post Thursday . 'When I first got the diagnosis I was shocked for sure,' he wrote. 'But, at least I could understand why I would be onstage and in a massive amount of nerve pain or, just feeling crazy fatigue or sickness.' Timberlake faced criticism for recent performances in Europe over what fans described as low-energy shows. It appears Lyme disease may be to blame. 'I was faced with a personal decision. Stop touring? Or, keep going and figure it out,' Timberlake wrote on Instagram. 'I decided the joy that performing brings me far outweighs the fleeting stress my body was feeling. I'm so glad I kept going.' Timberlake just completed his 'Forget Tomorrow World Tour' in Istanbul, Turkey on Tuesday. The tour started in Vancouver last April. A post shared by Justin Timberlake (@justintimberlake) Notable Canadian celebrities who have shared their diagnosis with Lyme disease include Avril Lavigne, Justin Bieber and Shania Twain. The blacklegged tick is known to transmit four tick-borne diseases — anaplasmosis, babesiosis, Lyme disease and Powassan virus — that are listed as Diseases of Public Health Significance by Public Health Ontario (PHO). Lyme disease occurs in stages. Symptoms can vary from person to person after being bitten by an infected blacklegged tick or western blacklegged tick. Signs and symptoms of each stage can overlap. 'In some people, Lyme disease may present in a later stage without a history of prior signs or symptoms,' the Public Health Agency of Canada (PHAC) explains. Early signs and symptoms of Lyme disease can manifest as: The erythema migrans rash is the most commonly reported sign of Lyme disease. PHAC explains it's an expanding skin rash that usually starts at the site of the tick bite slowly expanding over several days. The rash can be circular or oval-shaped, looking like a target or bull's eye. It can go unnoticed if it's on dark skin or a part of the body that's hard to see. PHAC says some people might not develop a rash at all. The bull's-eye shape of this rash is a clear sign of Lyme disease. Later symptoms of Lyme disease can appear days to months after an infected tick bite and might manifest as: In very rare cases, death can occur due to the complications involving an infection of the heart. Lyme disease is a growing concern in Canada particularly in southern Ontario, which is considered one of a few hot spots for ticks. Tick populations continue to climb in Ontario, as well as other parts of Canada. This year is expected to follow the trend . The Public Health Agency of Canada has a tool where you can type in your postal code and it will tell you if you're located in a risk area for Lyme disease. Some risk areas include spots in Windsor, Whitby, Waterloo, Uxbridge, The Blue Mountains, Tay Valley, St. Catharines, Smiths Falls, Scugog, Richmond Hill, Rideau Lakes, Renfrew, Prince Edward County, Port Hope, Perth, Peel, Ottawa, Oshawa, Orillia, Oakville, Niagara Falls, Newmarket, Mississauga, Milton, Markham, Hamilton, Clarington, Caledon, Burlington, Brampton, Kawartha Lakes, Barrie, Ajax and more. Map of five areas known for risk to tick exposure in Canada. The number of human reported Lyme disease cases in Canada in 2024 was 5,239, according to preliminary data from the PHAC. That's a jump from the 4,785 cases reported in 2023 and 2,525 in 2022. For a matter of perspective, only 144 cases were reported in 2009. Out of the 4,785 cases in 2023, 1,865 were reported in Ontario, according to Public Health Ontario data. In Canada, Lyme disease is caused by a bacterium called Borrelia burgdorferi, which is spread through the bite of infected blacklegged ticks — also known as deer ticks — and western blacklegged ticks, according to the PHAC. The blacklegged tick, or deer tick as it is sometimes called, is the most common carrier of Lyme disease. Despite the established risk areas for ticks, Public Health Ontario said it's important for people to know they could encounter an infected blacklegged tick almost anywhere in Ontario , as blacklegged ticks feed on and are transported by migratory birds. Species of ticks can be found in most parts of Ontario — clustering along the north shores of Lake Erie, Lake Ontario and the St. Lawrence River, according to PHO. This map depicts the estimated risk areas for Lyme disease in Ontario in 2024. Risk areas for Lyme disease in southern Ontario can be found along the north shores of Lake Erie and Lake Ontario and on the south shore of Lake Huron, according to PHAC . In southeastern Ontario, risk areas can be found around Kingston in the St. Lawrence valley, extending northeast toward Ottawa. PHO data shows Lyme disease was reported in all but one health unit region in 2023. The highest concentration of reported cases in Ontario in 2013 was in the Ontario health unit catchment areas of Hastings Prince Edward Public Health and Kingston, Frontenac, Lennox & Addington Public Health. In 2023, 84 people in Ontario were hospitalized for Lyme disease. PHO shows Lyme rates have been climbing for the last 10 years. Climate change is contributing to the spread of blacklegged ticks to new areas in Canada. Southern, western and southeastern Ontario, parts of Manitoba, southern Quebec and the Maritime provinces are known to be risk areas for ticks and Lyme disease exposure. Map of five areas known for risk to tick exposure in Canada. Lyme disease and other tick-borne illnesses can cause serious medical issues. Here are some proactive measures to take to avoid getting bitten by a tick. For more information on ticks , visit the Public Health Agency of Canada's website. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
